Prime Medicine, Inc. short interest in 2024
In 2024, Prime Medicine, Inc.'s disclosed short interest ran from 8.32% of shares outstanding on 12 Jan 2024 to 12.91% on 31 Dec 2024, a change of +4.59 percentage points. The year's high was 14.69% on 15 Oct 2024 and its low 8.32% on 12 Jan 2024, averaging 11.36% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 36.92 days on 30 Aug 2024. Full history: Prime Medicine, Inc..
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 8.32% (12 Jan 2024)
- End of year
- 12.91% (31 Dec 2024)
- Change
- +4.59 pp
- High
- 14.69% (15 Oct 2024)
- Low
- 8.32% (12 Jan 2024)
- Average
- 11.36%
- Highest days to cover
- 36.92 (30 Aug 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 8.32% | 16.50 | |
| 31 Jan 2024 | 9.36% | 15.10 | |
| 15 Feb 2024 | 10.63% | 11.38 | results (8-K) |
| 29 Feb 2024 | 9.48% | 12.23 | |
| 15 Mar 2024 | 9.93% | 16.54 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 10.20% | 22.49 | |
| 15 Apr 2024 | 10.49% | 12.94 | |
| 30 Apr 2024 | 11.18% | 12.36 | |
| 15 May 2024 | 9.37% | 13.85 | 10-Q filed, results (8-K) |
| 31 May 2024 | 9.54% | 11.18 | |
| 14 Jun 2024 | 9.64% | 13.03 | |
| 28 Jun 2024 | 10.59% | 9.80 | |
| 15 Jul 2024 | 11.43% | 19.05 | |
| 31 Jul 2024 | 12.43% | 23.09 | |
| 15 Aug 2024 | 13.24% | 23.02 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 13.55% | 36.92 | |
| 13 Sep 2024 | 13.81% | 27.15 | |
| 30 Sep 2024 | 13.93% | 4.53 | |
| 15 Oct 2024 | 14.69% | 10.12 | |
| 31 Oct 2024 | 12.04% | 15.02 | |
| 15 Nov 2024 | 11.58% | 13.92 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 12.02% | 12.53 | |
| 13 Dec 2024 | 12.30% | 14.24 | |
| 31 Dec 2024 | 12.91% | 13.07 |
See also: Prime Medicine, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.